Researcher at Japan stem cell institute falsified nearly all images in 2017 paper

Shinya Yamanaka

An investigation by Kyoto University in Japan has found a researcher guilty of falsifying all but one of the figures in a 2017 stem cell paper.

Yesterday, Kyoto University announced that the paper’s first author, Kohei Yamamizu, had fabricated and falsified data in the Stem Cell Reports paper. According to the investigation report, none of the other authors were involved in the data manipulation.

Yamamizu works at the Center for iPS cell Research and Application (CiRA) at Kyoto University, directed by Shinya Yamanaka, a Nobel Prize winner for his pioneering work in stem cell biology.

A spokesperson for the journal told us that the authors disclosed the problems last week and Stem Cell Reports will be retracting the paper, published last February.

In the university’s official statement, Yamanaka said: Continue reading Researcher at Japan stem cell institute falsified nearly all images in 2017 paper

Author retracts 2009 chemistry paper with “heavily doctored” images

A researcher has retracted a 2009 chemistry paper after discovering that a figure had been “inappropriately edited.”

According to the journal, a reader brought the images in question in Figure 1 to the editors’ attention last September. Timothy P. Lodge, distinguished professor at the University of Minnesota in Minneapolis — and editor of Macromolecules through December 2017 — told Retraction Watch:

Continue reading Author retracts 2009 chemistry paper with “heavily doctored” images

“A painful lesson:” Authors retract paper after discovering mislabeled mouse lines

Neuroscientists have retracted a 2016 paper examining the genetic underpinnings of a degenerative motor neuron disease, after discovering that two mouse lines had been accidentally mislabeled.

According to the retraction notice, published in December in Acta Neuropathologica Communications, mice engineered to have a specific genetic mutation were mislabeled as the normal or wild type group.

The notice cites an investigation by the University of Florida; we asked the university for a copy of the report. The university sent us a redacted document, which a spokesperson told us was a self-report from the researchers regarding the mislabeling. The spokesperson explained: Continue reading “A painful lesson:” Authors retract paper after discovering mislabeled mouse lines

Journal retracts letter for missing disclosure author says he tried to submit

An emergency medicine journal has retracted a letter to the editor, saying it didn’t include the author’s relevant commercial interest—which the author says he tried to disclose when he submitted the paper.

The author, Guy Weinberg, told Retraction Watch he had noted his conflict of interest when he submitted the letter last March, but said he did not use the journal’s disclosure form. He added that his primary concern is that the editors didn’t reach out to him to discuss the issue prior to retracting the letter.

Here’s the retraction notice for “Assessing Efficacy of Lipid in Unstable, non-LAST Overdose Patients,” published on Sept. 18 in the Canadian Journal of Emergency Medicine: Continue reading Journal retracts letter for missing disclosure author says he tried to submit

Authors who lost two papers for plagiarism will be fired from university: report

Researchers from Nepal who had two papers retracted last year for plagiarism will face sanctions, according to a local media report.

According to coverage last month from Republica, a news outlet in Nepal, the editor of Bali Medical Journal said he will blacklist the six authors. In a follow-up article, Dipak Shrestha, associate dean of Kathmandu University in Dhulikhel, Nepal, said the university plans to fire the four doctors who work there. (We contacted the journal and the university to confirm that the researchers have been blacklisted and fired, but have not heard back.)

Here’s the retraction notice for the 2013 paper, “Dyslipidemia in Type-2 Diabetes Mellitus Patients in Western of Nepal: A Hospital Based Study:” Continue reading Authors who lost two papers for plagiarism will be fired from university: report

A Cardinal sin? Communications researcher accused of plagiarizing former Pope

Peter Schulz

A communications researcher in Switzerland found guilty of plagiarism and sanctioned is facing more allegationsincluding that he plagiarized work by a former Pope.

Peter J. Schulz, who works at the University of Lugano, has already lost two book chapters. He also has retracted two papers and issued three errata; the errata note failing to properly cite other authors and plagiarism. In 2016, he was temporarily suspended by his university for misappropriating the work of others.

Most recently, Schulz has been accused of plagiarizing Pope John Paul II (who resigned died in 2005) and the English philosopher, Sir Anthony Kenny, in a 2001 book chapter. Continue reading A Cardinal sin? Communications researcher accused of plagiarizing former Pope

“Devastated” researchers worry co-author’s use of fake reviews could hurt their careers

In late December, Ana Khajehnezhad learned what no scientist wants to hear: One of her papers had been retracted. The reason: Her co-author had faked the reviews.

Khajehnezhad, who works at the Plasma Physics Research Center at Islamic Azad University in Tehran, Iran, told Retraction Watch she was “devastated” to hear the news:

I was so shocked. … I had absolutely no knowledge whatsoever on the actions taken by the corresponding author.

As we reported last month, Elsevier is retracting 26 papers affected by fake reviews; Ahmad Salar Elahi is corresponding author on 24 of them, including Khajehnezhad’s now-retracted paper published in International Journal of Hydrogen Energy. Many of Ehali’s co-authors are now facing the consequences of these retractions. Three of them shared their story. Continue reading “Devastated” researchers worry co-author’s use of fake reviews could hurt their careers

Accusations of ”false claims” in anti-global warming paper unresolved after three years

Three years after receiving a complaint about extensive plagiarism and major errors in an anti-global warming paper, Elsevier says it’s still reviewing the allegations.

In 2014, readers complained to the Elsevier journal Renewable and Sustainable Energy Reviews about plagiarism and technical flaws in a 2013 paper questioning mainstream climate change science.

When we first began reporting the story last year, a spokesperson for Elsevier told us:

Continue reading Accusations of ”false claims” in anti-global warming paper unresolved after three years

After Elsevier knew an author faked reviews, it kept accepting his papers for more than a year

In March 2017, Christopher Blanford received an email from an editor at the Journal of Crystal Growth. Blanford had been named as a suggested reviewer for a manuscript, and the editor, Arnab Bhattacharya, wanted to verify that the Gmail account the authors provided was legitimate.

It was not.

Blanford—a senior lecturer in biomaterials at the University of Manchester, UK—thought it was an “amusing coincidence” that he was chosen as a fake reviewer, given that he has written about malpractice in academic publishing. He confirmed the Gmail account was not his, and the other two suggested reviewers told Bhattacharya, a professor at the Tata Institute of Fundamental Research in Mumbai, India, the same thing.

Continue reading After Elsevier knew an author faked reviews, it kept accepting his papers for more than a year

Lead author changes co-author’s name on a paper without his permission. Why?

Here’s a rather odd case: A postdoctoral researcher says his former boss changed his name on a paper without his permission. According to the postdoc, Antonio Herrera-Merchan, his principal investigator at University of Granada insisted on the name change to distance them both from a scandal in Herrera-Merchan’s previous lab.

After publishing a paper in Oncotarget in October 2017, Herrera-Merchan’s name was changed on the paper. Now, two versions of the paper exist: an earlier version that lists Antonio Herrera-Merchan as first author, and the current version that spells his name without “Merchan.”*  

We’ve obtained an email exchange between his former boss, Pedro Medina, and Oncotarget, requesting the name change.

Medina told us Herrera-Merchan always used the name “Herrera” in his lab: Continue reading Lead author changes co-author’s name on a paper without his permission. Why?